Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD
NCT00574470
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Graft vs Host Disease
Interventions
DRUG:
daclizumab, infliximab
Sponsor
University of Iowa